Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

CUTISPHARMA, INC.;841 WOBURN ST;WILMINGTON;MA;01887

UEI: SLED_C7E981F346BDD3F0

CUTISPHARMA, INC.;841 WOBURN ST;WILMINGTON;MA;01887 is a federal contractor, registered under UEI SLED_C7E981F346BDD3F0. It has been awarded $5,000,000 across 1 federal contract. Primary work spans Pharmaceutical Preparation Manufacturing. Top awarding agencies include Nac Federal Supply Schedule (36F797).

Contact Information

Registration and classification details

Registration

UEI Code

SLED_C7E981F346BDD3F0

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Nac Federal Supply Schedule (36F797)$5.0M100%

Awards by NAICS

325412 - Pharmaceutical Preparation Manufacturing$5.0M100%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in CUTISPHARMA, INC.;841 WOBURN ST;WILMINGTON;MA;01887's top NAICS codes and agencies

ENROFLOXACIN INJECT

Solicitation # SPE2DP-26-T-4496

Enrofloxacin Injection, a veterinary antibiotic solution for dogs, is supplied at a concentration of 2.27% with a dosage of 2.5 mg per kilogram in a 20 mL volume, intended for intramuscular use in managing bacterial pathogens. The product is regulated by the FDA and requires strict adherence to shelf-life requirements, with a non-extendable shelf life of 24 months classified as a Type I (Code M) item. Storage must be maintained at or below 25 degrees Celsius with excursions permitted up to 40 degrees Celsius, and the product must be protected from direct sunlight and freezing. Packaging and marking must conform to the latest edition of the Medical Marking Standard No. 1, superseding all references to MIL-STD-129, and all units must be sealed in commercial containers designed to prevent damage and ensure safe transport. The item is procured under contract SPE2DP-26-T-4496 with a single unit of issue, delivered FOB destination within 81 days, with zero variance tolerance. Delivery is directed to the U.S. Medical Material Center in Kaiserslautern, Germany, with the required delivery date set for August 5, 2026. Supplier information includes Patterson Veterinary Supply, Inc. and Covetrus North America, LLC with designated part numbers, and all technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements. The contracting official must submit a referral via EBS for FDA-regulated product confirmation prior to award, including manufacturer and bidder details.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

NEOMYCIN AND POLYMYXIN

Solicitation # SPE2DP-26-T-4500

The contract covers the procurement of Neomycin and Polymyxin B Sulfates and Gramicidin, a regulated pharmaceutical product with NDC number 24208-0790-62, supplied by Bausch & Lomb Pharmaceuticals Division under the Veteran’s Health Joint Venture program. The item is classified as a TYPE I (CODE Q) with a strict non-extendable shelf life of 36 months, and all packaging must comply with Medical Marking Standard No. 1, superseding MIL-STD-129. Each unit must be sealed in a protective container and shipped in commercial exterior packaging suitable for safe transport by common carrier at the lowest cost to the delivery point, with all markings adhering to DLA’s medical marking standards. The product is subject to FDA regulation, requiring contracting officials to verify its status via EBS referral prior to award. The delivery is FOB destination, with required shipment within five days of award, and no quantity variance is permitted. The contract includes the NSN 6505-01-143-4643 and references the DLA Master List of Technical and Quality Requirements for applicable specifications, with the solicitation number SPE2DP-26-T-4500 and response deadline set for August 11, 2026. The item is procured under the authorized unit of issue BT (10 mL), with a total quantity of 3 units, and performance is to occur at Fort Lewis, WA. The contract is governed under federal acquisition protocols, and supplier submissions must include detailed information on the bidder, manufacturer, part number, and product description. All packaging and labeling must meet DLA’s technical and quality standards as defined in their official documentation.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

BENZOCAINE ORAL TOPICA

Solicitation # SPE2DP-26-T-4499

BENZOCAINE ORAL TOPICAL GEL 20% in a 1 oz 28g unit is being procured under contract SPE2DP-26-T-4499 with a single unit of issue BT equivalent to 28 grams and a required delivery within 20 days FOB destination. The item is classified as a TYPE I medical product with a fixed 36-month non-extendable shelf life and must comply with all technical and quality specifications referenced in the DLA Master List of Technical and Quality Requirements. Packaging must meet commercial standards and adhere strictly to Medical Marking Standard No. 1 superseding MIL-STD-129, ensuring each unit is sealed in protective containment and shipped in appropriate exterior containers suitable for safe delivery via common carrier at the lowest cost. The product must be marked and documented in accordance with DLA medical standards and all applicable defense information security requirements. The manufacturer is BEUTLICH PHARMACEUTICALS LLC with NDC 00283-0871-31, and the NSN is 6505010645769 with zero variance allowed in quantity. Inspection and acceptance occur at the destination point, and the entire procurement is governed by DLA’s unit of issue guidelines as defined in their official documentation, with all packaging conforming to MIL-STD-2073-1E.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

PRAZIQUANTEL, PYRANT

Solicitation # SPE2DP-26-T-4495

This contract specifies the procurement of veterinary tablets containing 22.7 mg praziquantel, 22.7 mg pyrantel pamoate, and 113.4 mg febantel, intended for use in puppies or small dogs weighing at least 2 pounds and older than 3 weeks, to treat and control tapeworms, hookworms, and whipworms. The product is packaged in bottles of 50 tablets each, with a total of three bottles required under this solicitation. The item has a non-extendable shelf life of 36 months and must be stored at controlled room temperature. Packaging must comply with MIL-STD-2073-1E and Medical Marking Standard No. 1, superseding MIL-STD-129, with all units sealed and protected to prevent damage during transit. Delivery is required FOB destination within 81 days, to a specified military medical logistics center in Kaiserslautern, Germany, with the final destination being APO AE 09227-0000. The product is classified as hazardous material, requiring full compliance with OSHA’s Hazard Communication Standard, including the submission of Safety Data Sheets and compliant labels in accordance with 29 C.F.R. 1910.1200, along with employee training on these requirements. The procurement falls under NSN 6509-01-578-7110, with a unit price of $3.00 per bottle and a total contract value of $9.00. All supplies must be labeled and marked per government medical standards, and the supplier must adhere to the revised Federal Standard No. 313-E as of June 1, 2015, to ensure safety and regulatory compliance for government use.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 7 hours ago

DEADLINE

6505--Supplies - Radioactive Isotopes - Ann Arbor

Solicitation # 36C25026Q0724_1

The U.S. Department of Veterans Affairs through the 250-NETWORK Contract Office 10 is soliciting offers for the supply of radioactive isotopes to support medical services at the Ann Arbor VA and Toledo CBOC under a full and open competition. The solicitation, numbered 36C25026Q0724_1, was posted on August 5, 2026, with proposals due by 3:00 p.m. Eastern Time on August 13, 2026. The contract falls under NAICS code 325412, which pertains to the manufacturing of radioactive radioisotopes, and is being procured through a combined solicitation requiring qualified vendors to respond with competitive pricing, technical compliance, and adherence to all regulatory and safety standards for handling and delivering radioactive materials. The contracting officer is Kellie Konopinski, reachable via phone at 734-222-4330 or email at kellie.konopinski@va.gov, and all correspondence must be directed through this point of contact. The place of performance is not explicitly defined in the provided details, but the supplies are intended for use at the Ann Arbor VA and Toledo CBOC facilities. The contract office is located in Dayton, Ohio, with a ZIP code of 45428, and all responses must comply with federal procurement regulations. There is no set-aside designation for small businesses or other categories, indicating the opportunity is open to all eligible contractors. The RFQ requires detailed technical and commercial proposals, including documentation of regulatory certifications, quality assurance protocols, and logistics capabilities to ensure timely delivery of isotopes under strict radiological safety conditions. The full requirements, including isotopes specifications, delivery schedules, packaging standards, and reporting obligations, are detailed in the attached RFQ document.

250-NETWORK Contract Office 10 (36C250)

POSTED

about 12 hours ago

DEADLINE

ISOPROPYL ALCOHOL

Solicitation # SPE2DP-26-T-4494

ISOPROPYL ALCOHOL USP, commonly known as rubbing alcohol, is a 99% isopropanol solution supplied in 473-milliliter bottles, equivalent to one pint or 16 ounces, and is classified as an over-the-counter product regulated by the FDA. It is highly flammable, poses serious eye irritation risks, and may cause drowsiness or dizziness, requiring storage at 20° to 25°C (68° to 77°F) away from heat, sparks, open flames, and hot surfaces with strict no-smoking protocols. The item is identified by NSN 6505-00-205-6513 and must comply with applicable hazardous materials regulations including 49 CFR and ICAO technical instructions. A current Material Safety Data Sheet (MSDS) is mandatory and must accompany each shipment, submitted electronically to DLA.MSDS@DLA.MIL alongside the required cover sheet P-75. Packaging must meet hazardous materials standards, and government identification must be removed from non-accepted supplies. This procurement is governed by DLA’s Master List of Technical and Quality Requirements, with the applicable revision determined by the solicitation or award date. The solicitation, issued under SPE2DP-26-T-4494 on August 4, 2026, with a response deadline of August 10, 2026, is for four bottles with a required delivery within five days to Pascagoula, Mississippi, under the NAICS code 325412, managed by the Department of Defense’s Medical Supply Chain Pharma FSA. All bidders must provide manufacturer details, part numbers, and item descriptions for FDA referral via EBS.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

BUPIVACAINE AND EPINEP

Solicitation # SPE2DP-26-T-4478

The contract specifies the procurement of Bupivacaine and Epinephrine Injection, containing 0.500% w/v Bupivacaine HCl and 0.005 mg Epinephrine per mL (1:200,000), packaged in 1.8 mL cartridges, with a unit of issue of one case containing 50 cartridges. The product must be stored at controlled room temperature between 15 and 30 degrees Celsius and must have a minimum shelf life of 15 months at the time of delivery to the first government activity, despite an 18-month maximum shelf life. All packaging and labeling must comply with Medical Marking Standard No. 1, replacing MIL-STD-129, and must be commercially packaged to ensure safe transit under ASTM D3951 or applicable hazardous material standards if classified as hazardous under FED-STD-313. The supply must be free of intentional mercury or mercury compounds, except where functionally necessary and explicitly exempted, and any permitted mercury-containing components must meet Navy shockproof and secondary containment requirements. Delivery is required FOB destination within 20 days to the USS Delaware (SSN 791) at FPO AE 09583, with no variance allowed in quantity, and shipment must use traceable, expedited methods with no parcel post. The item is identified by NSN 6505-01-189-3973 and purchase request 7017729383, with a required delivery date of August 6, 2026. All technical and quality requirements are governed by the DLA Master List of Technical and Quality Requirements, which supersedes any conflicting standards.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

VERAPAMIL HYDROCHLO

Solicitation # SPE2DP-26-T-4480

Verapamil Hydrochloride Extended-Release Tablets, 240 mg, are being procured in bottles of 100 tablets each, with a total quantity of two bottles required under contract SPE2DP-26-T-4480. The product must have a minimum of 31 months of shelf life remaining at the time of delivery, with a full 36-month shelf life specified and non-extendable. Packaging must comply strictly with DLA Packaging Requirements for Procurement and the latest Medical Marking Standard No. 1, superseding MIL-STD-129, and must ensure protection from damage during transit. All units must be commercially packaged in suitable exterior shipping containers, meeting the lowest freight rate standard for delivery to the specified destination. The item is regulated by the FDA, and the contracting official must confirm compliance via EBS referral. Manufacturer and distributor information includes Glenmark Pharmaceuticals Inc., USA and Cardinal Health 200, LLC, with the NDC number NDC68462-0260-01. The delivery is FOB destination, with a 20-day delivery window and no quantity variance permitted. Shipment must be traceable and cannot be sent via parcel post; instead, it must be transported using the FASTEST TRACEABLE MEANS with RDD 777 and referenced to the DLA vendor code V23027. The required delivery date is February 17, 2026, and the item is to be delivered to USS IWO JIMA LHD 7, FPO AA 34094. All packaging, labeling, and documentation must adhere to applicable DLA technical and quality requirements listed in the DLA Master List, which take precedence over ASTM D3951 and other commercial standards.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Solicitation # SPE2DP-26-T-4493

Carbon Dioxide, Technical, USP Cylinder Type E, is being procured in quantities of two units, each containing 6 pounds of gas at a minimum purity of 99.5 percent, pressurized to 1800 PSI, with a total filled weight of 20 pounds excluding the cap. The unit of issue is each (EA), and the material must conform to Medical Marking Standard No. 1, which replaces all references to MIL-STD-129; copies of this standard are available from DLA Troop Support via email or their official website. Each cylinder must be securely packaged in a sealed container to prevent damage or breakage, and shipped in commercially appropriate exterior containers that ensure safe delivery by common carrier at the lowest possible rate to the designated delivery point. Packaging requirements are governed by DLA Packaging Requirements for Procurement, and technical and quality specifications are referenced from the DLA Master List of Technical and Quality Requirements, with the applicable revision determined by the solicitation or award date depending on acquisition type. The item is identified by NSN 6505-01-212-7489 under Purchase Request 7017735431, with a delivery requirement of 20 days from award. Bidders must clearly state the source and part number being offered, and all supplies must comply with government guidelines for removal of identification from non-accepted items. The solicitation, issued under SPE2DP-26-T-4493 on August 4, 2026, with a response deadline of August 10, 2026, is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with Shairy M. Cartagena as the primary point of contact.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

PERMETHRIN CREAM RINSE

Solicitation # SPE2DP-26-T-4477

Permectrin Cream Rinse is a 1% w/v topical medication packaged as a 2 fl oz plastic squeeze bottle, each unit including a comb for application, and supplied in individual units with a minimum of 21 months of remaining shelf life at time of receipt by the government, ensuring a 24-month total shelf life is maintained. The item is regulated by the FDA and must comply with all applicable medical, packaging, and hazardous materials standards including Medical Marking Standard No. 1, which supersedes MIL-STD-129, and packaging requirements that ensure protection from damage during shipping and compliance with commercial standards for both interior and exterior containers. All shipments must include a current Safety Data Sheet (SDS) formatted per 29 C.F.R. 1910.1200, with labels meeting OSHA’s Hazard Communication Standard and the Globally Harmonized System, and these documents must be submitted for approval before contract award. Each shipment must also carry a copy of the SDS and be marked in accordance with the approved medical marking guidelines. The product is subject to DLA’s technical and quality requirements as outlined in the DLA Master List, and must comply with all applicable transportation regulations including 49 CFR and ICAO standards for hazardous materials. The NSN is 6505-01-256-4972, with two units requested under solicitation SPE2DP-26-T-4477, with a 20-day delivery requirement and a contract awarded to a government activity under the Department of Defense.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SODIUM PERBORATE

Solicitation # SPE2DP-26-T-4492

Sodium perborate in powder form, packaged in 100-gram bottles, is procured under contract SPE2DP-26-T-4492 for delivery to USS PORTLAND LPD 27 in San Diego, California. The item has a strict 36-month shelf life that is non-extendable and must be stored away from high humidity and temperatures exceeding 32 degrees Celsius, with separation from flammable materials. It is subject to defense information protections and incorporates technical and quality requirements from the DLA Master List, which supersede commercial standards. Packaging must comply with Medical Marking Standard No. 1, replacing MIL-STD-129, and adhere to DLA packaging specifications including palletization and hazardous material handling if applicable. The item is regulated by the FDA, requiring referral through EBS for product specialist confirmation. Delivery is FOB destination within 20 days, with no tolerance for quantity variance, and inspection and acceptance occur at the delivery point. The sole unit of issue is the bottle (BT), with one bottle ordered, and the NSN is 6505-01-307-3268. The contract identifies approved suppliers including Sultan Chemists Inc, Henry Schein Inc, and Patterson Dental Supply, with specific part numbers. Transportation procedures follow DLA directives, and the shipment must be labeled with the provided TCN and reference codes. The original required delivery date is August 6, 2026, with a response deadline of August 10, 2026 for the solicitation.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

CLINDAMYCIN PHOSPHA

Solicitation # SPE2DP-26-T-4488

CLINDAMYCIN PHOSPHATE TOPICAL SOLUTION, USP, is being procured under contract SPE2DP-26-T4488 with a quantity of 4 bottles, each containing 60 mL, identified by NSN 6505-01-116-5655 and NDC codes including PHARMACIA/UPJOHN 00009-3116-02 and FOUGERA 00168-0201-60. The product must be stored at controlled room temperature and protected from freezing. Packaging requirements mandate commercial standard unit containers that safeguard against damage or breakage, packed in suitable exterior shipping containers compliant with carrier requirements for safe, cost-effective delivery to the specified point. All labeling must adhere to Medical Marking Standard No. 1, replacing MIL-STD-129, and copies of this standard are available via DLA Troop Support. The solution is subject to hazardous materials regulations, requiring a current Material Safety Data Sheet to accompany each shipment and be submitted electronically to DLA.MSDS@DLA.MIL with the required cover sheet. Mercury and mercury-containing compounds are strictly prohibited in the product or its packaging except for limited, specified exemptions. The item is not TAA compliant under the Greenstone NDC code. Technical and quality requirements are governed by the DLA Master List, with revisions effective as of the solicitation date. Delivery is due within 10 days of award.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

SODIUM CHLORIDE INJ

Solicitation # SPE2DP-26-T-4367

Sodium Chloride 0.9% Injection, USP, 500 mL, 24 units per pack, is being procured under solicitation SPE2DP-26-T-4367 for delivery to the USS NEW ORLEANS LPD 18 at FPO AP 96673, with a required delivery window of 20 days after order placement and FOB Destination terms. The contract specifies a quantity of 10 packing groups, each containing 24 units, and mandates strict adherence to medical packaging and labeling standards, superseding MIL-STD-129 with Medical Marking Standard No. 1. The product is regulated by the FDA, and the contracting official must refer bidders through EBS for product specialist confirmation, including manufacturer details and NDC numbers. Packaging must be commercial and compliant with ASTM D3951 for non-hazardous materials, but DLA’s Master List of Technical and Quality Requirements takes precedence. A 24-month non-extendable shelf life applies, and mercury or mercury-containing compounds are prohibited unless exempted for specific functional uses such as batteries or instruments, with additional containment requirements per NAVSEA 5100-003D. Hazardous material handling must follow FED-STD-313 and TQ Requirement IP025, with labeling per OSHA’s Hazard Communication Standard. The item is subject to DFARS clauses covering safeguarding covered defense information, prohibition of certain telecommunications equipment, whistleblower rights, and restrictions on toxic or hazardous materials. Offerors must provide UEI and CAGE codes, represent their small business status if applicable, and comply with trafficking in persons, employment eligibility verification, and sustainable product requirements. All submissions must be made through DIBBS by August 4, 2026, and the contract will be evaluated under likely Low Price Technically Acceptable criteria. Payment will be processed via WAWF, and inspection and acceptance occur at the delivery point. Multiple manufacturers are listed as qualified suppliers, including Baxter Healthcare, B. Braun Medical, Cardinal Health, McKesson, and ICU Medical, each identified by their part numbers and NDC codes.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

TEST STRIPS AND COLOR

Solicitation # SPE2DS-26-T-305V

The contract specifies the procurement of test strips and color charts designed for urinalysis, detecting bilirubin, blood, glucose, ketone, leukocytes, nitrite, pH, protein, specific gravity, and urobilinogen. Each unit is packaged as a bottle containing 100 strips, with a total of three bottles required. The item, identified by NSN 6550-01-221-5400, must comply with stringent technical and quality standards referenced from the DLA Master List, and is subject to DLA packaging requirements, including commercial packaging standards and the Medical Marking Standard No. 1, which replaces MIL-STD-129. All packaging must ensure protection during transit and meet export requirements where applicable, with markings conforming to MMS1C for date of manufacture, expiration, contract number, and lot number. The product has a non-extendable shelf life of 18 months, and no more than two months may have passed from the date of manufacture to the delivery date to the government. Delivery is required within 20 days of award, and the contract is managed by the Department of Defense through the Medical Supply Chain MD Surg FSF office, with performance directed to Pearl Harbor, Hawaii. The solicitation, issued under SPE2DS-26-T-305V, was posted on August 4, 2026, with responses due by August 10, 2026.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

GLOBULIN, RHO (D) IMMUN

Solicitation # SPE2DP-26-T-4482

GLOBULIN RHO (D) IMMUNE, USP, 300 MICROGRAMS per 1ML disposable syringe with safety mechanism, is intended for intramuscular injection only and is designated for adult use. The product must be stored at 2 to 8 degrees Celsius and must not be frozen. It is a prescription-only item and packaged individually as a single unit. The item is regulated by the FDA and requires confirmation through the EBS referral system, including submission of bidder and manufacturer details. The NSN is 6505-01-417-1250, and it is subject to DLA packaging and technical requirements referenced in the DLA Master List of Technical and Quality Requirements. As a hazardous material, it requires a current Material Safety Data Sheet (MSDS) to be submitted to DLA.MSDS@DLA.MIL and physically included with each shipment, with packaging compliant with 49 CFR and ICAO regulations. This solicitation, issued under SPE2DP-26-T-4482 by the Department of Defense’s Medical Supply Chain PHARM FSA, has a response deadline of August 10, 2026, with a delivery requirement of 20 days after award. The point of contact for inquiries is James Foggie, with email and phone provided for coordination.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

APPLICATOR, SILVER NITR

Solicitation # SPE2DP-26-T-4469

The applicator consists of a 75% silver nitrate and 25% potassium nitrate mixture fused to one end, measuring six inches or 1.524 centimeters, and is intended for topical use only with a prescription requirement. Each unit of issue is a container holding 100 applicators, which must be stored in the original closed package at room temperature in a dark, dry location, away from organic or oxidizable materials. The item is classified as a Type I (Code M) shelf-life item with a non-extendable shelf life of 24 months. It is regulated by the FDA, and buyers must submit a referral in EBS to confirm product details including bidder and manufacturer information. Hazardous materials regulations apply, requiring a current MSDS to be submitted via DLA.MSDS@DLA.MIL and included with each shipment, with packaging compliant to SPE2DP-26-T-4469 and applicable 49 CFR and ICAO standards. Removal of government identification from non-accepted supplies is required, and covered defense information potentially applies. The NSN is 6505-00-299-9672, with a single contract order quantity and a 10-day delivery requirement after award. The solicitation, issued under SPE2DP-26-T-4469, was posted on August 4, 2026, with responses due by August 10, 2026, and is managed by the Department of Defense’s Medical Supply Chain Pharm FSA, with Nicholas Quigley listed as the primary point of contact.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

FLUCONAZOLE TABLETS

Solicitation # SPE2DP-26-T-4489

Fluconazole Tablets 150 mg are procured in individually sealed blister strips containing 12 tablets each, with the unit of issue defined as a package. The product must have a non-extendable shelf life of 24 months, and no more than three months may have elapsed from the date of manufacture to the date of delivery to the government. Packaging must comply with commercial standards and be designed to protect the contents from damage or breakage, with exterior shipping containers suitable for safe transport at the lowest possible rate to the delivery point. All markings must adhere to Medical Marking Standard No. 1, which replaces MIL-STD-129, and mercury or mercury-containing compounds are strictly prohibited from intentional addition or direct contact with the product, except for specified functional uses in batteries, instruments, or reagents under defined conditions. The item is identified by NSN 6505013953039 and NDC codes NDC51407-0426-12 and NDC62559-0992-12, and must be manufactured by Golden State Medical Supply, Inc. or ANIP Acquisition Co. The contract requires delivery within 20 days FOB destination, with zero variance allowed in quantity, and inspection and acceptance occurring at the destination. The solicitation is issued under SPE2DP-26-T-4489, with a response deadline of August 10, 2026, and performance is directed to Fort Campbell, with the Department of Defense as the contracting agency.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

HYDROGEN PEROXIDE TOPI

Solicitation # SPE2DP-26-T-4481

Hydrogen Peroxide Topical Solution USP RP001 is a 3% stabilized solution intended for external topical use only, not for ingestion or application to the eyes or large body areas, and must not be used for more than one week. Each unit of issue is a 473-milliliter bottle, requiring tight closure, storage at controlled room temperature, protection from freezing and excessive heat, and must not be shaken. Labeling and packaging must strictly comply with Medical Marking Standard No. 1A dated February 4, 2013, superseding MIL-STD-129, and all packaging must be commercially sealed and designed to prevent damage during transport. The item is regulated by the FDA and classified as a TYPE I (CODE M) item with a non-extendable shelf life of 24 months. As a hazardous material under OSHA’s revised Hazard Communication Standard effective June 1, 2015, suppliers must provide Safety Data Sheets (SDS) and compliant HCS labels per 29 C.F.R. 1910.1200, and must train employees on these requirements. The contract mandates delivery within 20 days to FPO AP 96693, FOB destination, with zero variance in quantity, and prohibits parcel post in favor of traceable shipping methods. The NSN is 6505-00-153-8480, with a contracted quantity of two bottles, procured under solicitation SPE2DP-26-T-4481, and all technical and quality requirements are governed by the DLA Master List, which supersedes ASTM D3951. Approved manufacturers include Medline Industries, LP, Cardinal Health 200, LLC, and McKesson Medical-Surgical Government, with the item identified by multiple NDC and part numbers. All deliveries must be palletized per RP001 requirements and marked per Medical Marking Standard No. 1.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE